Zantac
Boehringer Ingelheim Wins Zantac Cancer Lawsuits
Boehringer Ingelheim has successfully defended itself in two lawsuits claiming that its discontinued heartburn drug, Zantac, caused cancer.
A state court jury in…
Zantac Trial Against Boehringer Ends in Third Hung Jury
A trial in California state court concluded with a hung jury in a lawsuit alleging that the heartburn medication Zantac, formerly produced by…
GSK to Settle 80,000 Zantac Lawsuits for up to $2.2b
GSK has agreed to pay up to $2.2 billion to settle the majority of pending U.S. state court lawsuits alleging that a discontinued version of the heartburn medication…
GSK CEO Strives to Resolve Zantac Litigation Drag on Shares
GSK Plc’s CEO has made it a priority to ensure that the majority of the company’s employees remain focused on the company's core mission, rather than the ongoing…
GSK Wins as Florida Court Rejects Zantac-Cancer Testimony
GlaxoSmithKline (GSK) is seeking the dismissal of a Zantac lawsuit in Florida, following a favorable ruling by the state court judge to…